Are you over 18 and want to see adult content?
More Annotations
A complete backup of bibliocommons.com
Are you over 18 and want to see adult content?
A complete backup of metroportatil.com
Are you over 18 and want to see adult content?
A complete backup of secret-satire-society.org
Are you over 18 and want to see adult content?
A complete backup of hidrosfera.wordpress.com
Are you over 18 and want to see adult content?
A complete backup of magrocardona.com
Are you over 18 and want to see adult content?
A complete backup of espiritusantotourism.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://barts.eu
Are you over 18 and want to see adult content?
A complete backup of https://storeapps.org
Are you over 18 and want to see adult content?
A complete backup of https://smartbargains.com
Are you over 18 and want to see adult content?
A complete backup of https://akasakahikawa.or.jp
Are you over 18 and want to see adult content?
A complete backup of https://rivneosvita.org.ua
Are you over 18 and want to see adult content?
A complete backup of https://martindabek.com
Are you over 18 and want to see adult content?
A complete backup of https://brookeowensfellowship.org
Are you over 18 and want to see adult content?
A complete backup of https://ardelyx.com
Are you over 18 and want to see adult content?
A complete backup of https://poshcode.org
Are you over 18 and want to see adult content?
A complete backup of https://miped.ru
Are you over 18 and want to see adult content?
A complete backup of https://chanbrothers.com
Are you over 18 and want to see adult content?
A complete backup of https://pinchmegood.com
Are you over 18 and want to see adult content?
Text
ZIPDOSE TECHNOLOGY
zipdose TECHNOLOGY the world's first 3dp dosage form. Developed with Aprecia’s proprietary 3DP manufacturing process, ZipDose® Technology helps patients who need medicines that are easy to take and caregivers—including physicians and nurse practitioners—who wantmedicines that are
NEWS | PRESS RELEASES | APRECIA Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. February 23,IDEAS - APRECIA
Ideas LEADING A NEW AGE OF DIGITAL MEDICINE. We believe in a future where every patient can have a precision dose of medicine delivered to a precise area of the body at precisely the right time.EVENTS - APRECIA
Events join the discussion on 3dp for pharma at these upcoming events and webinars. Aprecia is pleased to share the following Webinars and expert content around 3DP pharmaceutical applications. REDEFINING FAST MELT FOR PHARMA REDEFINING FAST MELT FOR PHARMA. 3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher ESTIMATING THE INCREMENTAL BURDEN OF DYSPHAGIA IN EPILEPSYSEE MORENEW CONTENT WILL BE ADDED ABOVE THE CURRENT AREA OF FOCUS UPON SELECTIONSEE MORE ON APRECIA.COM FIRST FDA-APPROVED MEDICINE MANUFACTURED USING 3D PRINTINGSEE MORE ONAPRECIA.COM
ABOUT US | 3DP | APRECIA Aprecia is the global leader in commercial-scale 3DP for pharmaceutical manufacturing technology. Committed to creating new solutions for unmet healthcare needs by developing pharma-ready innovations and complementary technology platforms that help take medicine to its fullest potential. KIRK DONALDSON JOINS APRECIA TO LEAD GLOBAL BUSINESS Kirk Donaldson, VP, Business Development &Alliance Management CINCINNATI OH, September 5, 2019 – Aprecia, the 3DP Pharmaceutical Company, today announced that Kirk Donaldson has been named Vice President of Business Development and Alliance Management.Donaldson will lead the company’s business development efforts as it continues to drive global access to its proprietary 3D-printing APRECIA | 3D PRINTING IN MEDICINEPRODUCTSIDEASEVENTSGET STARTEDOUR SOLUTIONSLIFECYCLE MANAGEMENT Aprecia is the global leader in 3DP pharmaceutical manufacturing and the world’s first and only FDA-validated, commercial scale technology for 3D printing in medicine.ZIPDOSE TECHNOLOGY
zipdose TECHNOLOGY the world's first 3dp dosage form. Developed with Aprecia’s proprietary 3DP manufacturing process, ZipDose® Technology helps patients who need medicines that are easy to take and caregivers—including physicians and nurse practitioners—who wantmedicines that are
NEWS | PRESS RELEASES | APRECIA Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. February 23,IDEAS - APRECIA
Ideas LEADING A NEW AGE OF DIGITAL MEDICINE. We believe in a future where every patient can have a precision dose of medicine delivered to a precise area of the body at precisely the right time.EVENTS - APRECIA
Events join the discussion on 3dp for pharma at these upcoming events and webinars. Aprecia is pleased to share the following Webinars and expert content around 3DP pharmaceutical applications. REDEFINING FAST MELT FOR PHARMA REDEFINING FAST MELT FOR PHARMA. 3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher ESTIMATING THE INCREMENTAL BURDEN OF DYSPHAGIA IN EPILEPSYSEE MORENEW CONTENT WILL BE ADDED ABOVE THE CURRENT AREA OF FOCUS UPON SELECTIONSEE MORE ON APRECIA.COM FIRST FDA-APPROVED MEDICINE MANUFACTURED USING 3D PRINTINGSEE MORE ONAPRECIA.COM
ABOUT US | 3DP | APRECIA Aprecia is the global leader in commercial-scale 3DP for pharmaceutical manufacturing technology. Committed to creating new solutions for unmet healthcare needs by developing pharma-ready innovations and complementary technology platforms that help take medicine to its fullest potential. KIRK DONALDSON JOINS APRECIA TO LEAD GLOBAL BUSINESS Kirk Donaldson, VP, Business Development &Alliance Management CINCINNATI OH, September 5, 2019 – Aprecia, the 3DP Pharmaceutical Company, today announced that Kirk Donaldson has been named Vice President of Business Development and Alliance Management.Donaldson will lead the company’s business development efforts as it continues to drive global access to its proprietary 3D-printingCONTACT - APRECIA
Contact. Thank you for your interest in Aprecia. If you would like more information about Aprecia business opportunities or if you have any general questions, please feel free to contact us. contact@aprecia.com. Aprecia Pharmaceuticals - Corporate HQ. 10901 Kenwood Rd. Blue Ash, OH 45242. (513) 984-5000. Map.IDEAS - APRECIA
Ideas LEADING A NEW AGE OF DIGITAL MEDICINE. We believe in a future where every patient can have a precision dose of medicine delivered to a precise area of the body at precisely the right time. SOLUTIONS | THE FUTURE OF PHARMA | APRECIA SOLUTIONS PARTNERSHIP AND OPPORTUNITY. THE CORE OF OUR SOLUTIONS PORTFOLIO. Welcome to the future of pharmaceutical manufacturing. Collaboration with our partners and customers assures high quality prescription medicines can be made available when and where they areneeded.
APRECIA ESTABLISHES A LONG-TERM PARTNERSHIP WITH BATTELLE Aprecia Establishes a Long-Term Partnership with Battelle. CINCINNATI, Ohio and COLUMBUS, Ohio — Aprecia is partnering with Battelle to accelerate and expand its advanced capabilities in 3DP pharmaceutical manufacturing. The collaboration will be focused on advancing 3DP equipment from clinical supply through commercial scale, while NANOFORM AND APRECIA COLLABORATE TO ADVANCE 3D PRINTED Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. APRECIA AND CMIC, A LEADING CDMO IN JAPAN, HAVE CINCINNATI, OH and Minato-ku, Tokyo, March 7, 2019 – Privately held Aprecia Pharmaceuticals, LLC (“Aprecia”) and CMIC CMO Co., LTD (“CMIC CMO”) today announced that both companies will collaborate to develop business opportunities in Japan for Aprecia’s ZipDose® Technology. CMIC CMO’s services will include identifying prospects in Japan, generating awareness and facilitatingZIPDOSE TECHNOLOGY
Introducing in-cavity printing. Since 2004, Aprecia has led the way in commercial scale 3D-printing technology for pharmaceutical products. First, Aprecia pioneered the use of “open bed” 3D printing at scale to support centralized manufacturing of pharmaceutical products, culminating in FDA approval of the first pharmaceutical product using3D printing.
TECHNOLOGY | 3D PRINTED DRUGS | APRECIA TECHNOLOGY THE FUTURE OF PHARMACEUTICAL MANUFACTURING. Available today. Our combination of innovative 3DP technologies and proven, low-risk manufacturing strategies can help you keep existing medicines on the market longer, maximize the potential of your R&D pipeline, and ultimately reach the patients you serve sooner. FIRST FDA-APPROVED MEDICINE MANUFACTURED USING 3D PRINTING SPRITAM is the first prescription drug product approved by the U.S. Food and Drug Administration (FDA) that is manufactured using 3D printing technology. This innovative product disintegrates in the mouth with a sip of liquid and offers a new option for patients, including those who may struggle to PRACTICAL APPLICATIONS FOR 3DP DRUG MANUFACTURING: TODAY The emergence of 3DP for Pharma is a significant industry advancement, as it will ultimately revolutionize the way we manufacture drugs in the digital age. The pharmaceutical industry can benefit from Aprecia’s ZipDose technology, the world’s first APRECIA | 3D PRINTING IN MEDICINEPRODUCTSIDEASEVENTSGET STARTEDOUR SOLUTIONSLIFECYCLE MANAGEMENT Aprecia is the global leader in 3DP pharmaceutical manufacturing and the world’s first and only FDA-validated, commercial scale technology for 3D printing in medicine.ZIPDOSE TECHNOLOGY
zipdose TECHNOLOGY the world's first 3dp dosage form. Developed with Aprecia’s proprietary 3DP manufacturing process, ZipDose® Technology helps patients who need medicines that are easy to take and caregivers—including physicians and nurse practitioners—who wantmedicines that are
CONTACT - APRECIA
Contact. Thank you for your interest in Aprecia. If you would like more information about Aprecia business opportunities or if you have any general questions, please feel free to contact us. contact@aprecia.com. Aprecia Pharmaceuticals - Corporate HQ. 10901 Kenwood Rd. Blue Ash, OH 45242. (513) 984-5000. Map. NEWS | PRESS RELEASES | APRECIA Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. February 23, REDEFINING FAST MELT FOR PHARMA REDEFINING FAST MELT FOR PHARMA. 3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher SOLUTIONS | THE FUTURE OF PHARMA | APRECIA Welcome to the future of pharmaceutical manufacturing. Collaboration with our partners and customers assures high quality prescription medicines can be made available when and where they are needed. We work with leading pharmaceutical companies to identify business and medical opportunities within new and existing product lines, includinglife
TECHNOLOGY | 3D PRINTED DRUGS | APRECIA TECHNOLOGY THE FUTURE OF PHARMACEUTICAL MANUFACTURING. Available today. Our combination of innovative 3DP technologies and proven, low-risk manufacturing strategies can help you keep existing medicines on the market longer, maximize the potential of your R&D pipeline, and ultimately reach the patients you serve sooner. APRECIA AND CMIC, A LEADING CDMO IN JAPAN, HAVE CINCINNATI, OH and Minato-ku, Tokyo, March 7, 2019 – Privately held Aprecia Pharmaceuticals, LLC (“Aprecia”) and CMIC CMO Co., LTD (“CMIC CMO”) today announced that both companies will collaborate to develop business opportunities in Japan for Aprecia’s ZipDose® Technology. CMIC CMO’s services will include identifying prospects in Japan, generating awareness and facilitating ABOUT US | 3DP | APRECIA Aprecia is the global leader in commercial-scale 3DP for pharmaceutical manufacturing technology. Committed to creating new solutions for unmet healthcare needs by developing pharma-ready innovations and complementary technology platforms that help take medicine to its fullest potential. KIRK DONALDSON JOINS APRECIA TO LEAD GLOBAL BUSINESS Kirk Donaldson, VP, Business Development &Alliance Management CINCINNATI OH, September 5, 2019 – Aprecia, the 3DP Pharmaceutical Company, today announced that Kirk Donaldson has been named Vice President of Business Development and Alliance Management.Donaldson will lead the company’s business development efforts as it continues to drive global access to its proprietary 3D-printing APRECIA | 3D PRINTING IN MEDICINEPRODUCTSIDEASEVENTSGET STARTEDOUR SOLUTIONSLIFECYCLE MANAGEMENT Aprecia is the global leader in 3DP pharmaceutical manufacturing and the world’s first and only FDA-validated, commercial scale technology for 3D printing in medicine.ZIPDOSE TECHNOLOGY
zipdose TECHNOLOGY the world's first 3dp dosage form. Developed with Aprecia’s proprietary 3DP manufacturing process, ZipDose® Technology helps patients who need medicines that are easy to take and caregivers—including physicians and nurse practitioners—who wantmedicines that are
CONTACT - APRECIA
Contact. Thank you for your interest in Aprecia. If you would like more information about Aprecia business opportunities or if you have any general questions, please feel free to contact us. contact@aprecia.com. Aprecia Pharmaceuticals - Corporate HQ. 10901 Kenwood Rd. Blue Ash, OH 45242. (513) 984-5000. Map. NEWS | PRESS RELEASES | APRECIA Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) pharmaceutical company, announce that they are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. February 23, REDEFINING FAST MELT FOR PHARMA REDEFINING FAST MELT FOR PHARMA. 3DP is ushering in a new age of pharmaceutical manufacturing. And ZipDose technology, the world’s first and only FDA-validated, commercial-scale 3DP for pharma, is opening new possibilities in new therapeutic areas for drug manufacturers. With the fastest fast-melt capability available, significantly higher SOLUTIONS | THE FUTURE OF PHARMA | APRECIA Welcome to the future of pharmaceutical manufacturing. Collaboration with our partners and customers assures high quality prescription medicines can be made available when and where they are needed. We work with leading pharmaceutical companies to identify business and medical opportunities within new and existing product lines, includinglife
TECHNOLOGY | 3D PRINTED DRUGS | APRECIA TECHNOLOGY THE FUTURE OF PHARMACEUTICAL MANUFACTURING. Available today. Our combination of innovative 3DP technologies and proven, low-risk manufacturing strategies can help you keep existing medicines on the market longer, maximize the potential of your R&D pipeline, and ultimately reach the patients you serve sooner. APRECIA AND CMIC, A LEADING CDMO IN JAPAN, HAVE CINCINNATI, OH and Minato-ku, Tokyo, March 7, 2019 – Privately held Aprecia Pharmaceuticals, LLC (“Aprecia”) and CMIC CMO Co., LTD (“CMIC CMO”) today announced that both companies will collaborate to develop business opportunities in Japan for Aprecia’s ZipDose® Technology. CMIC CMO’s services will include identifying prospects in Japan, generating awareness and facilitating ABOUT US | 3DP | APRECIA Aprecia is the global leader in commercial-scale 3DP for pharmaceutical manufacturing technology. Committed to creating new solutions for unmet healthcare needs by developing pharma-ready innovations and complementary technology platforms that help take medicine to its fullest potential. KIRK DONALDSON JOINS APRECIA TO LEAD GLOBAL BUSINESS Kirk Donaldson, VP, Business Development &Alliance Management CINCINNATI OH, September 5, 2019 – Aprecia, the 3DP Pharmaceutical Company, today announced that Kirk Donaldson has been named Vice President of Business Development and Alliance Management.Donaldson will lead the company’s business development efforts as it continues to drive global access to its proprietary 3D-printingCONTACT - APRECIA
Contact. Thank you for your interest in Aprecia. If you would like more information about Aprecia business opportunities or if you have any general questions, please feel free to contact us. contact@aprecia.com. Aprecia Pharmaceuticals - Corporate HQ. 10901 Kenwood Rd. Blue Ash, OH 45242. (513) 984-5000. Map.PRODUCTS - APRECIA
products the first and only proven 3dp platform commercially available today. Our three-dimensionally printed (3DP) platform for pharmaceutical manufacturing is the first and only to be FDA-validated and ready today for commercial scale drug development.IDEAS - APRECIA
Ideas LEADING A NEW AGE OF DIGITAL MEDICINE. We believe in a future where every patient can have a precision dose of medicine delivered to a precise area of the body at precisely the right time. APRECIA ESTABLISHES A LONG-TERM PARTNERSHIP WITH BATTELLE Aprecia Establishes a Long-Term Partnership with Battelle. CINCINNATI, Ohio and COLUMBUS, Ohio — Aprecia is partnering with Battelle to accelerate and expand its advanced capabilities in 3DP pharmaceutical manufacturing. The collaboration will be focused on advancing 3DP equipment from clinical supply through commercial scale, while TECHNOLOGY | 3D PRINTED DRUGS | APRECIA TECHNOLOGY THE FUTURE OF PHARMACEUTICAL MANUFACTURING. Available today. Our combination of innovative 3DP technologies and proven, low-risk manufacturing strategies can help you keep existing medicines on the market longer, maximize the potential of your R&D pipeline, and ultimately reach the patients you serve sooner.EVENTS - APRECIA
Events join the discussion on 3dp for pharma at these upcoming events and webinars. Aprecia is pleased to share the following Webinars and expert content around 3DP pharmaceutical applications. LIFECYCLE MANAGEMENT Lifecycle Management Vision, expertise and innovation for pharma product lifecycle management. From early-stage development through commercial-stage manufacturing, we partner with you to define your product and market needs, develop the right solutions, and streamline your pharma product lifecycle management process to help efficiently commercialize your products faster.ZIPDOSE TECHNOLOGY
Introducing in-cavity printing. Since 2004, Aprecia has led the way in commercial scale 3D-printing technology for pharmaceutical products. First, Aprecia pioneered the use of “open bed” 3D printing at scale to support centralized manufacturing of pharmaceutical products, culminating in FDA approval of the first pharmaceutical product using3D printing.
FIRST FDA-APPROVED MEDICINE MANUFACTURED USING 3D PRINTING SPRITAM is the first prescription drug product approved by the U.S. Food and Drug Administration (FDA) that is manufactured using 3D printing technology. This innovative product disintegrates in the mouth with a sip of liquid and offers a new option for patients, including those who may struggle to FDA APPROVES THE FIRST 3D PRINTED DRUG PRODUCT FDA Approves The First 3d Printed Drug Product. BLUE ASH, Ohio, August 3, 2015 – Aprecia Pharmaceuticals Company today announced that the U.S. Food and Drug Administration (FDA) has approved SPRITAM® levetiracetam for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary SolutionsOur Solutions Lifecycle ManagementNew Chemical Entity
TEchnologyOur Technology ZipDose Technologyproducts IDEAS
AboutAbout Us Partners & Business DevelopmentCareers News
Contact Us Events Get StartedMenu
3DP FOR PHARMA
TAKING YOUR PHARMACEUTICAL PRODUCT TO ITSFULLEST POTENTIAL.
As the world’s first and only FDA-validated, commercial scale three-dimensional printing (3DP) pharmaceutical manufacturer, we’re enabling the next generation of pharmaceutical manufacturing today – and taking medicine to its fullest potential in the new age of digitalmedicine.
MEDICINE AND MANUFACTURING REIMAGINED TODAY Our mission is two-fold: to help our pharmaceutical manufacturing partners seize business advantage by providing unique solutions to unmet patient needs. Today, from product concept to commercial stage manufacturing, we’re actively developing a suite of pharma-ready innovations and complementary technology platforms to enable the patient-centric products and precision medicines of the future.ENTIRELY NEW
DOSE FORMS
Rapid dispersion, high drug load, modified-release are just a few of the new dose forms 3DP for pharma delivers. Get started today with rapid disperse ZipDose® technology. NEW OPPORTUNITIES FOR IMPROVED THERAPEUTICS Our 3DP for Pharma platform can improve and enable new strategies for delivery and adherence across all therapeutic areas to improve quality of life for patients everywhere. MARKET EXCLUSIVITY OPPORTUNITIES 3DP pharmaceuticals create patent opportunities through new formulations, enhancing the innovation value of pipeline product candidates and extending marketed product lines, so you can expand market share far beyond generic manufacturers capabilities. EXPLORE THE POSSIBILITIES MEETING MORE PATIENT NEEDS MORE EFFECTIVELY Our advanced patient-centric approach to 3DP pharmaceutical design and production creates precision medicine, delivering the optimum dose at the right time to the right location. FOR PATIENTS WITH DYSPHAGIA New fast-melt capabilities unlocked by 3D printing in medicine eliminate the time and effort it takes patients who have difficulty swallowing to get the right dose when they need it. FOR ADHERENCE CHALLENGES Unprecedented combinations of high drug loading with rapid oral dispersion alleviate pill burden and adherence challenges, making medicine easier to take. FOR UNMET PATIENT NEEDS New ability to combine multiple functionalities in a single tablet – pre-gastric absorption, two or more APIs, modified release profiles, rapid dispersion in the oral cavity or alternative delivery sites. With ZipDose technology, you can offer patients pills that dissolve fast, carry higher dose load and mask taste.Our ZIPDOSE TechnologY EARLY STAGE SOLUTIONS ACCELERATE TIME-TO-MARKET From early-stage development to late-stage commercialization, our 3DP technologies provide formulation and manufacturing solutions that translate more quickly to final product scale, bringing significant business advantages to your bottom line. Use breakthrough dosage form functionality to minimize R&D iterations of dosing frequency and dose size Provide real-time formulation support for adaptive clinical trials Accommodate fragile molecules and particles to enable and speed the translation to final product scale Produce first in-human dosage forms using 3DP technologies with powerful advantages over other early-stage approachesWhite paper
REDEFINING FAST MELT FOR PHARMADownload White paper A BROAD SPECTRUM OF NEW PRODUCT POSSIBILITIES As the global leader of 3D printing in medicine, we give our partners the ability to develop formulations beyond the limitations of compression method tableting, bringing you and the patients you serve substantial benefits today.LET'S GET STARTED
Schedule a 3DP Discovery Assessment to learn how we can help you open new market opportunities with innovative dose forms. CONTACT US AT (513) 984-5000 •CONTACT@APRECIA.COM
Try a free sample of our 3D printed ZipDose Technology ▸Contact Us
Solutions
_ _|_ _Technology
_ _|_ _Ideas
_ _|_ _About
_ _|_ _Jobs
_ _|_ _partnerships
_ _|_ _CONTACT US
Privacy | Terms of Use 2018 Aprecia Pharmaceuticals, LLC. All rights reserved.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0